Dopamine Receptor Ligand Selectivity—An In Silico/In Vitro Insight

Different dopamine receptor (DR) subtypes are involved in pathophysiological conditions such as Parkinson’s Disease (PD), schizophrenia and depression. While many DR-targeting drugs have been approved by the U.S. Food and Drug Administration (FDA), only a very small number are truly selective for on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zell, Lukas, Bretl, Alina, Temml, Veronika, Schuster, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216180/
https://www.ncbi.nlm.nih.gov/pubmed/37239139
http://dx.doi.org/10.3390/biomedicines11051468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216180/
https://www.ncbi.nlm.nih.gov/pubmed/37239139
http://dx.doi.org/10.3390/biomedicines11051468

Ejemplares similares